title: Metformin Improves Insulin Signaling in Obese Rats via Reduced IKKbeta Action in a Fiber-Type Specific Manner.
abstract: Metformin is a widely used insulin-sensitizing drug, though its mechanisms are not fully understood. Metformin has been shown to activate AMPK in skeletal muscle; however, its effects on the inhibitor of kappaB kinasebeta (IKKbeta) in this same tissue are unknown. The aim of this study was to (1) determine the ability of metformin to attenuate IKKbeta action, (2) determine whether changes in AMPK activity are associated with changes in IKKbeta action in skeletal muscle, and (3) examine whether changes in AMPK and IKKbeta function are consistent with improved insulin signaling. Lean and obese male Zuckers received either vehicle or metformin by oral gavage daily for four weeks (four groups of eight). Proteins were measured in white gastrocnemius (WG), red gastrocnemius (RG), and soleus. AMPK phosphorylation increased (P < .05) in WG in both lean (57%) and obese (106%), and this was supported by an increase in phospho-ACC in WG. Further, metformin increased IkappaBalpha levels in both WG (150%) and RG (67%) of obese rats, indicative of reduced IKKbeta activity (P < .05), and was associated with reduced IRS1-pSer(307) (30%) in the WG of obese rats (P < .02). From these data we conclude that metformin treatment appears to exert an inhibitory influence on skeletal muscle IKKbeta activity, as evidenced by elevated IkappaBalpha levels and reduced IRS1-Ser(307) phosphorylation in a fiber-type specific manner.
authors.affiliation: The Metabolic Institute for the Study of Diabetes and Obesity, East Carolina University, Greenville, NC 27834, USA.
authors.forename: Benjamin T
authors.initials: BT
authors.lastname: Bikman
authors.forename: Donghai
authors.initials: D
authors.lastname: Zheng
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Kane
authors.forename: Ethan J
authors.initials: EJ
authors.lastname: Anderson
authors.forename: Tracey L
authors.initials: TL
authors.lastname: Woodlief
authors.forename: Jesse W
authors.initials: JW
authors.lastname: Price
authors.forename: G Lynis
authors.initials: GL
authors.lastname: Dohm
authors.forename: P Darrell
authors.initials: PD
authors.lastname: Neufer
authors.forename: Ronald N
authors.initials: RN
authors.lastname: Cortright
references.citation: J Clin Invest. 2001 Aug;108(3):437-46
references.pmid: 11489937
references.citation: Am J Physiol Endocrinol Metab. 2003 Apr;284(4):E726-32
references.pmid: 12488242
references.citation: Biochem Biophys Res Commun. 2004 May 28;318(2):372-80
references.pmid: 15120611
references.citation: Biochem Biophys Res Commun. 2009 Nov 13;389(2):211-6
references.pmid: 19706288
references.citation: J Clin Endocrinol Metab. 2001 Mar;86(3):1306-12
references.pmid: 11238525
references.citation: Am J Physiol Endocrinol Metab. 2009 Apr;296(4):E955-64
references.pmid: 19208854
references.citation: J Biol Chem. 2004 Oct 1;279(40):41294-301
references.pmid: 15252018
references.citation: JAMA. 2004 Mar 10;291(10):1238-45
references.pmid: 15010446
references.citation: Int J Obes Relat Metab Disord. 2003 Dec;27 Suppl 3:S6-11
references.pmid: 14704736
references.citation: J Clin Endocrinol Metab. 2008 Dec;93(12):4656-63
references.pmid: 18765510
references.citation: J Neurosci. 2004 Jan 14;24(2):479-87
references.pmid: 14724246
references.citation: Nature. 2006 Dec 14;444(7121):860-7
references.pmid: 17167474
references.citation: Diabetes. 2004 Jul;53(7):1649-54
references.pmid: 15220186
references.citation: Am J Physiol Regul Integr Comp Physiol. 2006 Jan;290(1):R233-40
references.pmid: 16081881
references.citation: Nat Med. 2005 Feb;11(2):183-90
references.pmid: 15685173
references.citation: Am J Physiol Cell Physiol. 2005 Oct;289(4):C794-801
references.pmid: 15888549
references.citation: Curr Med Chem. 2006;13(5):583-9
references.pmid: 16515522
references.citation: Biochem Biophys Res Commun. 2004 Nov 26;324(4):1204-9
references.pmid: 15504342
references.citation: Nature. 1998 Nov 5;396(6706):77-80
references.pmid: 9817203
references.citation: J Clin Invest. 2000 Aug;106(4):473-81
references.pmid: 10953022
references.citation: Diabetes. 2002 Aug;51(8):2420-5
references.pmid: 12145153
references.citation: Ann N Y Acad Sci. 2002 Jun;967:146-57
references.pmid: 12079844
references.citation: Diabetes. 2004 Dec;53(12):3258-66
references.pmid: 15561958
references.citation: Am J Physiol Endocrinol Metab. 2006 Feb;290(2):E251-7
references.pmid: 16118254
references.citation: Diabetes. 2002 Jul;51(7):2005-11
references.pmid: 12086926
references.citation: Science. 2001 Aug 31;293(5535):1673-7
references.pmid: 11533494
references.citation: J Physiol. 2006 Dec 15;577(Pt 3):997-1007
references.pmid: 17008371
references.citation: Hypertension. 2006 Jun;47(6):1183-8
references.pmid: 16636195
references.citation: Circulation. 2004 Jan 27;109(3):433-8
references.pmid: 14744958
references.citation: Hepatology. 2009 May;49(5):1525-36
references.pmid: 19296465
references.citation: Diabetes. 2002 Jan;51(1):7-18
references.pmid: 11756317
references.citation: Diabetologia. 2009 Dec;52(12):2616-20
references.pmid: 19809797
references.citation: Am J Physiol. 1997 Dec;273(6):E1107-12
references.pmid: 9435525
references.citation: Biochem J. 2000 Jun 15;348 Pt 3:607-14
references.pmid: 10839993
references.citation: J Clin Invest. 2005 May;115(5):1111-9
references.pmid: 15864338
references.citation: Am J Physiol Endocrinol Metab. 2002 Jan;282(1):E18-23
references.pmid: 11739078
references.citation: J Appl Physiol (1985). 2006 Dec;101(6):1685-92
references.pmid: 16902066
references.citation: Nat Med. 2005 Feb;11(2):191-8
references.pmid: 15685170
references.citation: Cell Metab. 2006 Dec;4(6):465-74
references.pmid: 17141630